These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2909956)

  • 1. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome.
    Maniscalco WM; Kendig JW; Shapiro DL
    Pediatrics; 1989 Jan; 83(1):1-6. PubMed ID: 2909956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
    Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM; Dalton J
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement therapy for respiratory distress syndrome. American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 1999 Mar; 103(3):684-5. PubMed ID: 10049980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials.
    Kendig JW; Notter RH; Cox C; Aschner JL; Benn S; Bernstein RM; Hendricks-Munoz K; Maniscalco WM; Metlay LA; Phelps DL
    Pediatrics; 1988 Nov; 82(5):756-62. PubMed ID: 3054783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of neonatal respiratory distress syndrome with surfactant BL].
    Zatovka GN; Duginova SA; Safarov AA; Nechaeva MV; Blauberg EN
    Anesteziol Reanimatol; 2006; (1):38-43. PubMed ID: 16613043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.